You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 18, 2025

Details for Patent: 9,050,311


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,050,311 protect, and when does it expire?

Patent 9,050,311 protects ORENITRAM and is included in one NDA.

This patent has nineteen patent family members in seven countries.

Summary for Patent: 9,050,311
Title:Compounds and methods for delivery of prostacyclin analogs
Abstract: This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have the following formula: ##STR00001##
Inventor(s): Phares; Ken (Chapel Hill, NC), Mottola; David (Cary, NC), Batra; Hitesh (Herndon, VA)
Assignee: United Therapeutics Corporation (Silver Spring, MD)
Application Number:13/906,585
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,050,311
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,050,311: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article delves into the specifics of United States Patent 9,050,311, exploring its claims, scope, and the broader patent landscape.

Background of Patent 9,050,311

While the specific details of Patent 9,050,311 are not provided in the sources, we can infer general principles from similar patents and the patent system as a whole. Patents typically include a detailed description of the invention, drawings, and claims that define the scope of the invention.

Patent Claims: Definition and Importance

Patent claims are the legal definitions of the invention and are crucial for determining the scope of protection. They are typically divided into independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims[3].

Metrics for Measuring Patent Scope

Researchers have developed metrics to measure patent scope, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

The Role of Claim Language

The language used in patent claims is pivotal. It must be precise yet broad enough to cover the invention without being overly vague. The length and count of independent claims can indicate the complexity and breadth of the patent. For example, patents with fewer but more detailed independent claims may have a narrower scope but are often clearer and more valid[3].

Patent Examination Process

The examination process is a critical phase where the patent office evaluates the claims for novelty, non-obviousness, and utility. The scope of the claims can significantly influence the outcome of this process. Narrower claims are generally easier to examine and more likely to be granted quickly compared to broader claims, which may face more scrutiny and challenges[3].

Global Dossier and International Patent Landscape

In the global context, tools like the Global Dossier facilitate the management of related patent applications across different jurisdictions. This service provides access to file histories, classifications, and citation data, helping inventors and patent attorneys navigate the international patent landscape more efficiently[4].

Public Access to Patent Information

Public access to patent information is essential for transparency and innovation. Resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer extensive databases and trained staff to assist in patent searches. These resources help in understanding the existing patent landscape and avoiding potential infringements[4].

Common Citation Document (CCD)

The Common Citation Document (CCD) is another valuable tool that consolidates prior art citations from multiple patent offices. This helps in identifying relevant prior art and ensuring that the claims of a patent are novel and non-obvious across different jurisdictions[4].

Small Claims Patent Court: A Potential Future Development

There is ongoing discussion about the establishment of a small claims patent court to address issues related to patent litigation costs and complexity. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, particularly for small inventors and businesses[5].

Economic Impact of Patent Scope

The scope of a patent can have significant economic implications. Broader patents may lead to increased licensing and litigation costs, potentially discouraging innovation. On the other hand, narrower, well-defined patents can foster a more predictable and stable intellectual property environment, encouraging further innovation[3].

Case Study: Prostacyclin Derivatives Patent

Although not directly related to Patent 9,050,311, the patent for the synthesis of intermediates for producing prostacyclin derivatives (CA 2964804) illustrates the complexity of patent claims. This patent involves detailed chemical processes and specific claims that define the scope of the invention. The patent's scope is critical for ensuring that the inventors' rights are protected while allowing for further research and development in the field[1].

Key Takeaways

  • Patent Claims: Define the legal boundaries of an invention and are crucial for determining patent scope.
  • Metrics for Scope: Independent claim length and count are key metrics for assessing patent breadth and clarity.
  • Examination Process: The scope of claims influences the examination outcome, with narrower claims generally being easier to grant.
  • Global Dossier: Facilitates international patent management by providing access to related application data.
  • Public Access: Resources like the USPTO Public Search Facility and PTRCs are essential for transparency and innovation.
  • Economic Impact: Patent scope affects licensing and litigation costs, influencing the overall innovation environment.

FAQs

What are the key components of a patent?

A patent includes a detailed description of the invention, drawings, and claims that define the scope of the invention.

How do independent and dependent claims differ?

Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims.

What metrics are used to measure patent scope?

Metrics such as independent claim length and independent claim count are used to measure patent scope.

Why is the language of patent claims important?

The language must be precise yet broad enough to cover the invention without being overly vague, affecting the patent's validity and scope.

How does the Global Dossier help in patent management?

The Global Dossier provides access to file histories, classifications, and citation data for related patent applications across different jurisdictions.

What is the potential impact of a small claims patent court?

A small claims patent court could provide a more streamlined and cost-effective way to resolve patent disputes, particularly for small inventors and businesses.

Sources

  1. Canadian Patents Database: Patent 2964804 Summary.
  2. USPTO: Patent Claims Research Dataset.
  3. SSRN: Patent Claims and Patent Scope.
  4. USPTO: Search for patents.
  5. ACUS: U.S. Patent Small Claims Court.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,050,311

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
United Therap ORENITRAM treprostinil diolamine TABLET, EXTENDED RELEASE;ORAL 203496-001 Dec 20, 2013 RX Yes No 9,050,311 ⤷  Subscribe Y Y ⤷  Subscribe
United Therap ORENITRAM treprostinil diolamine TABLET, EXTENDED RELEASE;ORAL 203496-002 Dec 20, 2013 RX Yes No 9,050,311 ⤷  Subscribe Y Y ⤷  Subscribe
United Therap ORENITRAM treprostinil diolamine TABLET, EXTENDED RELEASE;ORAL 203496-003 Dec 20, 2013 RX Yes Yes 9,050,311 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 3 of 3 entries

International Family Members for US Patent 9,050,311

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Canada 2526534 ⤷  Subscribe
Canada 2736406 ⤷  Subscribe
Canada 2851309 ⤷  Subscribe
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.